Announced Thu, 1 Oct, 2026 · 18:51 IST

AGM 2026: All resolutions passed with over 99 percent support

Board & Shareholder Meetings View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.5%Reaction day
₹20.50
prior close
₹21.51
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.0%+1.5% vs market
Non Banking Financial Company (NBFC) peers, median of 221sector-0.0%+1.5% vs sector

On the reaction day the stock moved 1.5 pts more than Nifty Microcap 250 and 1.5 pts more than its Non Banking Financial Company (NBFC) peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+0.0
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.5+0.0+1.5-0.0+1.5
Next day
+0.4+1.3-0.9-0.3+0.7
2d
+4.4+1.1+3.3-0.2+4.6
3d
+7.3-1.7+9.0-2.2+9.5
4d
+4.9-1.4+6.3-1.7+6.6
5d
+3.4-0.6+4.0-1.3+4.7
1w
+8.0+0.3+7.8-0.5+8.6
15d
-4.9-6.1+1.2-4.9-0.0
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Non Banking Financial Company (NBFC) peers, median of 221Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Bazel International held its 44th AGM on 30 Sept 2026. All 8 valid resolutions passed with 99.49 percent support (16,49,708 in favor vs 8,526 against). Key items: FY26 financial statements approved, G. Anshul and Associates appointed as statutory auditor, Mayank Ahuja as Non-Executive Director, authorised capital increase and Bazel ESOP 2026 approved. Mr. Kawal Singh director appointment was withdrawn after his 28 Sept resignation. Only 17.68 percent of shares were polled.

Likely market impact

ESOP 2026 approval and authorised capital increase may lead to future share dilution; otherwise routine AGM business with strong approval margins.